Singapore markets closed

iX Biopharma Ltd. (42C.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.24000.0000 (0.00%)
At close: 5:04PM SGT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
Total revenue
757
671
6,533
6,381
Cost of revenue
1,537
1,200
5,156
4,448
Gross profit
-780
-529
1,377
1,933
Operating expenses
Research development
2,649
3,765
8,031
4,811
Selling general and administrative
8,273
7,845
8,673
7,593
Total operating expenses
10,906
11,594
16,687
10,467
Operating income or loss
-11,686
-12,123
-15,310
-8,534
Interest expense
230
232
267
242
Income before tax
-12,093
-13,268
-15,155
-7,581
Income tax expense
-5
-22
-61
-191
Income from continuing operations
-12,088
-13,246
-15,094
-7,390
Net income
-1,913
-2,991
-15,094
-7,390
Net income available to common shareholders
-1,913
-2,991
-15,094
-7,390
Basic EPS
-
-0.00
-0.02
-0.01
Diluted EPS
-
-0.00
-0.02
-0.01
Basic average shares
-
643,830
641,549
638,406
Diluted average shares
-
647,930
641,549
638,406
EBITDA
-
-11,820
-13,481
-6,058